StockData
West Pharmaceutical Services Inc logo

West Pharmaceutical Services Inc (WST) stock

WSTNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 20/3047% above fair value
$414.12−3.68 (-0.88%)

Close on Nov 17, 2026Market cap $28.85BP/E 46.5Yield 0.21%

West Pharmaceutical Services total assets

Total assets on the balance sheet at the end of each period.

West Pharmaceutical Services's total assets was $4.06B at Sep 30, 2026. For fiscal 2025 it was $4.27B, up 17.2% from the year before. Over ten years it grew 9.7% a year on average. The highest annual figure on record is $4.27B in fiscal 2025.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$4.27B+17.2%
FY2024Dec 31, 2024$3.64B-4.9%
FY2023Dec 31, 2023$3.83B+5.9%
FY2022Dec 31, 2022$3.62B+9.1%
FY2021Dec 31, 2021$3.31B+18.6%
FY2020Dec 31, 2020$2.79B+19.3%
FY2019Dec 31, 2019$2.34B+18.3%
FY2018Dec 31, 2018$1.98B+6.2%
FY2017Dec 31, 2017$1.86B+8.5%
FY2016Dec 31, 2016$1.72B+1.3%
FY2015Dec 31, 2015$1.70B+1.5%
FY2014Dec 31, 2014$1.67B-0.0%
FY2013Dec 31, 2013$1.67B+6.8%
FY2012Dec 31, 2012$1.56B+11.8%
FY2011Dec 31, 2011$1.40B+8.1%
FY2010Dec 31, 2010$1.29B+1.8%
FY2009Dec 31, 2009$1.27B–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$4.06B-1.1%
Q2 FY2026Jun 30, 2026$4.08B+3.1%
Q1 FY2026Mar 31, 2026$4.11B+13.6%
Q4 FY2025Dec 31, 2025$4.27B+17.2%
Q3 FY2025Sep 30, 2025$4.11B+11.7%
Q2 FY2025Jun 30, 2025$3.95B+13.3%
Q1 FY2025Mar 31, 2025$3.62B+0.4%
Q4 FY2024Dec 31, 2024$3.64B-4.9%
Q3 FY2024Sep 30, 2024$3.68B-2.1%
Q2 FY2024Jun 30, 2024$3.49B-4.9%
Q1 FY2024Mar 31, 2024$3.60B-3.3%
Q4 FY2023Dec 31, 2023$3.83B+5.9%
Q3 FY2023Sep 30, 2023$3.75B+13.2%
Q2 FY2023Jun 30, 2023$3.67B+9.2%
Q1 FY2023Mar 31, 2023$3.72B+13.0%
Q4 FY2022Dec 31, 2022$3.62B+9.1%
Q3 FY2022Sep 30, 2022$3.32B+5.5%
Q2 FY2022Jun 30, 2022$3.36B+14.6%
Q1 FY2022Mar 31, 2022$3.29B+20.3%
Q4 FY2021Dec 31, 2021$3.31B+18.6%
Q3 FY2021Sep 30, 2021$3.14B+21.7%
Q2 FY2021Jun 30, 2021$2.93B+22.6%
Q1 FY2021Mar 31, 2021$2.74B+22.0%
Q4 FY2020Dec 31, 2020$2.79B+19.3%
Q3 FY2020Sep 30, 2020$2.58B+18.8%
Q2 FY2020Jun 30, 2020$2.39B+12.7%
Q1 FY2020Mar 31, 2020$2.25B+10.3%
Q4 FY2019Dec 31, 2019$2.34B+18.3%
Q3 FY2019Sep 30, 2019$2.17B+11.7%
Q2 FY2019Jun 30, 2019$2.12B+13.3%
Q1 FY2019Mar 31, 2019$2.04B+8.9%
Q4 FY2018Dec 31, 2018$1.98B+6.2%
Q3 FY2018Sep 30, 2018$1.95B+0.8%
Q2 FY2018Jun 30, 2018$1.87B+1.7%
Q1 FY2018Mar 31, 2018$1.87B+7.9%
Q4 FY2017Dec 31, 2017$1.86B+8.5%
Q3 FY2017Sep 30, 2017$1.93B–
Q2 FY2017Jun 30, 2017$1.84B–
Q1 FY2017Mar 31, 2017$1.73B–
Q4 FY2016Dec 31, 2016$1.72B–

More West Pharmaceutical Services figures

See a number that looks wrong?